• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[度伐利尤单抗、吉西他滨和顺铂联合化疗治疗肝内胆管癌后的病理完全缓解——病例报告]

[Pathological Complete Response after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma-A Case Report].

作者信息

Hata Tomoki, Yasuyama Akinobu, Hara Takeo, Okano Miho, Takayama Osamu, Kim Yongkook, Hasegawa Junichi, Imamoto Haruhiko

机构信息

Dept. of Surgery, Kaizuka City Hospital.

出版信息

Gan To Kagaku Ryoho. 2025 Feb;52(2):167-169.

PMID:40073897
Abstract

The patient was a 66-year-old man. He came to our hospital because of abdominal discomfort. A CT scan revealed hypovascular tumors of about 70 mm in the S4/5 and 16 mm in the S6 of the liver. The S4/5 tumor was directly invasive into the greater omentum and abdominal wall, and a nodule suspected of peritoneal dissemination was observed around the tumor. Based on tumor biopsy results, a diagnosis of intrahepatic cholangiocarcinoma(ICC), cT3N0M1, Stage ⅣB was made. A total of 9 courses of GCD therapy(gemcitabine+cisplatin+durvalumab)were performed for ICC and the tumor was found to have shrunk, and the S6 tumor was obscured. The FDG-PET/CT scan also showed similar results, and the patient was judged to be curative, and surgery was performed 8 months after the initial diagnosis. Laparoscopic hepatic S4a/5 subsegmentectomy and S6 partial hepatectomy were performed. Intraoperative findings showed no peritoneal dissemination, and cytology of washed ascites was negative. Histopathological examination did not reveal any tumor cells, and the patient was judged to have a pathological complete response(pCR). There are few reports of ICC with pCR after GCD therapy, and we report this case here with a review of the literature.

摘要

患者为一名66岁男性。他因腹部不适前来我院就诊。CT扫描显示肝脏S4/5段有一个约70mm的乏血供肿瘤,S6段有一个16mm的肿瘤。S4/5段肿瘤直接侵犯大网膜和腹壁,肿瘤周围可见一个疑似腹膜播散的结节。根据肿瘤活检结果,诊断为肝内胆管癌(ICC),cT3N0M1,ⅣB期。针对ICC共进行了9个疗程的GCD治疗(吉西他滨+顺铂+度伐利尤单抗),发现肿瘤缩小,S6段肿瘤显示不清。FDG-PET/CT扫描也显示了类似结果,患者被判定为可治愈,并在初次诊断8个月后进行了手术。实施了腹腔镜肝S4a/5亚段切除术和S6部分肝切除术。术中发现无腹膜播散,冲洗腹水的细胞学检查为阴性。组织病理学检查未发现任何肿瘤细胞,患者被判定为病理完全缓解(pCR)。GCD治疗后出现pCR的ICC报道较少,我们在此报告该病例并进行文献复习。

相似文献

1
[Pathological Complete Response after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma-A Case Report].[度伐利尤单抗、吉西他滨和顺铂联合化疗治疗肝内胆管癌后的病理完全缓解——病例报告]
Gan To Kagaku Ryoho. 2025 Feb;52(2):167-169.
2
[A Case of Bullous Pemphigoid after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma].[度伐利尤单抗、吉西他滨和顺铂联合化疗治疗肝内胆管癌后发生大疱性类天疱疮1例]
Gan To Kagaku Ryoho. 2025 Feb;52(2):170-172.
3
[A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1].[吉西他滨、顺铂和S-1新辅助化疗后经转化手术有效治疗的晚期肝内胆管癌病例]
Gan To Kagaku Ryoho. 2022 Dec;49(13):1665-1667.
4
[Surgical Resection after Gemcitabine plus Cisplatin Chemotherapy for Intrahepatic Cholangiocarcinoma with Multiple Lymph Node Metastases - Report of a Case].[吉西他滨联合顺铂化疗后手术切除治疗多发淋巴结转移的肝内胆管癌——1例报告]
Gan To Kagaku Ryoho. 2016 Nov;43(12):1764-1766.
5
Conversion Surgery Performed Following Durvalumab Combined With Gemcitabine and Cisplatin in Cholangiocarcinoma: A Case Report.度伐利尤单抗联合吉西他滨和顺铂治疗胆管癌后进行的转化手术:1例病例报告
In Vivo. 2025 May-Jun;39(3):1724-1730. doi: 10.21873/invivo.13974.
6
[A case of curative resection after downsizing chemotherapy in initially unresectable locally advanced intrahepatic cholangiocarcinoma].[1例初始不可切除的局部晚期肝内胆管癌经降期化疗后行根治性切除术的病例]
Gan To Kagaku Ryoho. 2014 Nov;41(12):1509-11.
7
Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report.肝内胆管细胞癌转移患者一线化疗后维持治疗的延迟反应:一例报告
J Med Case Rep. 2017 Sep 26;11(1):273. doi: 10.1186/s13256-017-1443-8.
8
[A Case of Liver Metastasis of Intrahepatic Cholangiocarcinoma That Achieved Clinical Complete Response after Gemcitabine and Cisplatin Combination Chemotherapy].[吉西他滨联合顺铂化疗后达到临床完全缓解的肝内胆管癌肝转移病例]
Gan To Kagaku Ryoho. 2019 Feb;46(2):360-362.
9
Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma.初始不可切除的远端胆管癌化疗后的病理完全缓解
Clin J Gastroenterol. 2025 Apr;18(2):357-362. doi: 10.1007/s12328-024-02084-w. Epub 2024 Dec 28.
10
Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.对于接受度伐利尤单抗联合顺铂和吉西他滨治疗失败的MET扩增晚期肝内胆管癌患者,特泊替尼展现出卓越的持续长期完全缓解。
Oncologist. 2024 Dec 6;29(12):1090-1094. doi: 10.1093/oncolo/oyae265.